{
    "matches": [
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "12",
                    "Percentage of total G3+ events in HIV group": "30.0%"
                },
                "measures": "[Event count]",
                "outcomes": "[12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Hepatobiliary disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "12",
                    "30.0%"
                ]
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "15",
                    "Percentage of total G3+ events in HIV group": "25.0%"
                },
                "measures": "[Event count]",
                "outcomes": "[15]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Hepatobiliary disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "15",
                    "25.0%"
                ]
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "7",
                    "Percentage of total G3+ events in HIV group": "17.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "7",
                    "Percentage of total G3+ events in HIV group": "17.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "7",
                    "Percentage of total G3+ events in HIV group": "17.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "7",
                    "Percentage of total G3+ events in HIV group": "17.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "7",
                    "Percentage of total G3+ events in HIV group": "17.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "7",
                    "Percentage of total G3+ events in HIV group": "17.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "7",
                    "Percentage of total G3+ events in HIV group": "17.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "7",
                    "Percentage of total G3+ events in HIV group": "17.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "13",
                    "Percentage of total G3+ events in HIV group": "21.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[13]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "13",
                    "Percentage of total G3+ events in HIV group": "21.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[13]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "13",
                    "Percentage of total G3+ events in HIV group": "21.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[13]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "13",
                    "Percentage of total G3+ events in HIV group": "21.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[13]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "13",
                    "Percentage of total G3+ events in HIV group": "21.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[13]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "13",
                    "Percentage of total G3+ events in HIV group": "21.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[13]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "13",
                    "Percentage of total G3+ events in HIV group": "21.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[13]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "13",
                    "Percentage of total G3+ events in HIV group": "21.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[13]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "6",
                    "Percentage of total G3+ events in HIV group": "15.0%"
                },
                "measures": "[Event count]",
                "outcomes": "[6]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "6",
                    "Percentage of total G3+ events in HIV group": "15.0%"
                },
                "measures": "[Event count]",
                "outcomes": "[6]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "6",
                    "Percentage of total G3+ events in HIV group": "15.0%"
                },
                "measures": "[Event count]",
                "outcomes": "[6]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "6",
                    "Percentage of total G3+ events in HIV group": "15.0%"
                },
                "measures": "[Event count]",
                "outcomes": "[6]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "6",
                    "Percentage of total G3+ events in HIV group": "15.0%"
                },
                "measures": "[Event count]",
                "outcomes": "[6]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "6",
                    "Percentage of total G3+ events in HIV group": "15.0%"
                },
                "measures": "[Event count]",
                "outcomes": "[6]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "6",
                    "Percentage of total G3+ events in HIV group": "15.0%"
                },
                "measures": "[Event count]",
                "outcomes": "[6]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "6",
                    "Percentage of total G3+ events in HIV group": "15.0%"
                },
                "measures": "[Event count]",
                "outcomes": "[6]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "10",
                    "Percentage of total G3+ events in HIV group": "16.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[10]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "10",
                    "Percentage of total G3+ events in HIV group": "16.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[10]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "10",
                    "Percentage of total G3+ events in HIV group": "16.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[10]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "10",
                    "Percentage of total G3+ events in HIV group": "16.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[10]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "10",
                    "Percentage of total G3+ events in HIV group": "16.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[10]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "10",
                    "Percentage of total G3+ events in HIV group": "16.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[10]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "10",
                    "Percentage of total G3+ events in HIV group": "16.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[10]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "10",
                    "Percentage of total G3+ events in HIV group": "16.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[10]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "3",
                    "Percentage of total G3+ events in HIV group": "7.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[3]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "3",
                    "Percentage of total G3+ events in HIV group": "7.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[3]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "3",
                    "Percentage of total G3+ events in HIV group": "7.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[3]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "3",
                    "Percentage of total G3+ events in HIV group": "7.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[3]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "3",
                    "Percentage of total G3+ events in HIV group": "7.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[3]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "3",
                    "Percentage of total G3+ events in HIV group": "7.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[3]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "3",
                    "Percentage of total G3+ events in HIV group": "7.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[3]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "3",
                    "Percentage of total G3+ events in HIV group": "7.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[3]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "5",
                    "Percentage of total G3+ events in HIV group": "8.3%"
                },
                "measures": "[Event count]",
                "outcomes": "[5]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "5",
                    "Percentage of total G3+ events in HIV group": "8.3%"
                },
                "measures": "[Event count]",
                "outcomes": "[5]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "5",
                    "Percentage of total G3+ events in HIV group": "8.3%"
                },
                "measures": "[Event count]",
                "outcomes": "[5]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "5",
                    "Percentage of total G3+ events in HIV group": "8.3%"
                },
                "measures": "[Event count]",
                "outcomes": "[5]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "5",
                    "Percentage of total G3+ events in HIV group": "8.3%"
                },
                "measures": "[Event count]",
                "outcomes": "[5]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "5",
                    "Percentage of total G3+ events in HIV group": "8.3%"
                },
                "measures": "[Event count]",
                "outcomes": "[5]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "5",
                    "Percentage of total G3+ events in HIV group": "8.3%"
                },
                "measures": "[Event count]",
                "outcomes": "[5]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "5",
                    "Percentage of total G3+ events in HIV group": "8.3%"
                },
                "measures": "[Event count]",
                "outcomes": "[5]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "3",
                    "Percentage of total G3+ events in HIV group": "7.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[3]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "3",
                    "Percentage of total G3+ events in HIV group": "7.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[3]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "3",
                    "Percentage of total G3+ events in HIV group": "7.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[3]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "3",
                    "Percentage of total G3+ events in HIV group": "7.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[3]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "3",
                    "Percentage of total G3+ events in HIV group": "7.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[3]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "3",
                    "Percentage of total G3+ events in HIV group": "7.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[3]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "3",
                    "Percentage of total G3+ events in HIV group": "7.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[3]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "3",
                    "Percentage of total G3+ events in HIV group": "7.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[3]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "4",
                    "Percentage of total G3+ events in HIV group": "6.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "4",
                    "Percentage of total G3+ events in HIV group": "6.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "4",
                    "Percentage of total G3+ events in HIV group": "6.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "4",
                    "Percentage of total G3+ events in HIV group": "6.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "4",
                    "Percentage of total G3+ events in HIV group": "6.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "4",
                    "Percentage of total G3+ events in HIV group": "6.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "4",
                    "Percentage of total G3+ events in HIV group": "6.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "4",
                    "Percentage of total G3+ events in HIV group": "6.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "9",
                    "Percentage of total G3+ events in HIV group": "17.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[9]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "9",
                    "Percentage of total G3+ events in HIV group": "17.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[9]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "9",
                    "Percentage of total G3+ events in HIV group": "17.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[9]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "9",
                    "Percentage of total G3+ events in HIV group": "17.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[9]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "9",
                    "Percentage of total G3+ events in HIV group": "17.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[9]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "9",
                    "Percentage of total G3+ events in HIV group": "17.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[9]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "9",
                    "Percentage of total G3+ events in HIV group": "17.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[9]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "9",
                    "Percentage of total G3+ events in HIV group": "17.5%"
                },
                "measures": "[Event count]",
                "outcomes": "[9]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "13",
                    "Percentage of total G3+ events in HIV group": "16.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[13]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "13",
                    "Percentage of total G3+ events in HIV group": "16.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[13]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "13",
                    "Percentage of total G3+ events in HIV group": "16.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[13]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "13",
                    "Percentage of total G3+ events in HIV group": "16.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[13]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "13",
                    "Percentage of total G3+ events in HIV group": "16.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[13]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "13",
                    "Percentage of total G3+ events in HIV group": "16.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[13]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "13",
                    "Percentage of total G3+ events in HIV group": "16.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[13]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Event count": "13",
                    "Percentage of total G3+ events in HIV group": "16.7%"
                },
                "measures": "[Event count]",
                "outcomes": "[13]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing \u22651 AE": "20",
                    "Percentage of patients experiencing \u22651 AE": "47.6%"
                },
                "measures": "[Patients experiencing \u22651 AE]",
                "outcomes": "[20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing \u22651 AE": "20",
                    "Percentage of patients experiencing \u22651 AE": "47.6%"
                },
                "measures": "[Patients experiencing \u22651 AE]",
                "outcomes": "[20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing \u22651 AE": "20",
                    "Percentage of patients experiencing \u22651 AE": "47.6%"
                },
                "measures": "[Patients experiencing \u22651 AE]",
                "outcomes": "[20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing \u22651 AE": "20",
                    "Percentage of patients experiencing \u22651 AE": "47.6%"
                },
                "measures": "[Patients experiencing \u22651 AE]",
                "outcomes": "[20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing \u22651 AE": "20",
                    "Percentage of patients experiencing \u22651 AE": "47.6%"
                },
                "measures": "[Patients experiencing \u22651 AE]",
                "outcomes": "[20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing \u22651 AE": "20",
                    "Percentage of patients experiencing \u22651 AE": "47.6%"
                },
                "measures": "[Patients experiencing \u22651 AE]",
                "outcomes": "[20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing \u22651 AE": "20",
                    "Percentage of patients experiencing \u22651 AE": "47.6%"
                },
                "measures": "[Patients experiencing \u22651 AE]",
                "outcomes": "[20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing \u22651 AE": "20",
                    "Percentage of patients experiencing \u22651 AE": "47.6%"
                },
                "measures": "[Patients experiencing \u22651 AE]",
                "outcomes": "[20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing \u22651 AE": "34",
                    "Percentage of patients experiencing \u22651 AE": "15.5%"
                },
                "measures": "[Patients experiencing \u22651 AE]",
                "outcomes": "[34]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing \u22651 AE": "34",
                    "Percentage of patients experiencing \u22651 AE": "15.5%"
                },
                "measures": "[Patients experiencing \u22651 AE]",
                "outcomes": "[34]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing \u22651 AE": "34",
                    "Percentage of patients experiencing \u22651 AE": "15.5%"
                },
                "measures": "[Patients experiencing \u22651 AE]",
                "outcomes": "[34]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing \u22651 AE": "34",
                    "Percentage of patients experiencing \u22651 AE": "15.5%"
                },
                "measures": "[Patients experiencing \u22651 AE]",
                "outcomes": "[34]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing \u22651 AE": "34",
                    "Percentage of patients experiencing \u22651 AE": "15.5%"
                },
                "measures": "[Patients experiencing \u22651 AE]",
                "outcomes": "[34]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing \u22651 AE": "34",
                    "Percentage of patients experiencing \u22651 AE": "15.5%"
                },
                "measures": "[Patients experiencing \u22651 AE]",
                "outcomes": "[34]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing \u22651 AE": "34",
                    "Percentage of patients experiencing \u22651 AE": "15.5%"
                },
                "measures": "[Patients experiencing \u22651 AE]",
                "outcomes": "[34]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing \u22651 AE": "34",
                    "Percentage of patients experiencing \u22651 AE": "15.5%"
                },
                "measures": "[Patients experiencing \u22651 AE]",
                "outcomes": "[34]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients with treatment-related AE": "11",
                    "Percentage of patients with treatment-related AE": "26.2%"
                },
                "measures": "[Patients with treatment-related AE]",
                "outcomes": "[11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients with treatment-related AE": "11",
                    "Percentage of patients with treatment-related AE": "26.2%"
                },
                "measures": "[Patients with treatment-related AE]",
                "outcomes": "[11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients with treatment-related AE": "11",
                    "Percentage of patients with treatment-related AE": "26.2%"
                },
                "measures": "[Patients with treatment-related AE]",
                "outcomes": "[11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients with treatment-related AE": "11",
                    "Percentage of patients with treatment-related AE": "26.2%"
                },
                "measures": "[Patients with treatment-related AE]",
                "outcomes": "[11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients with treatment-related AE": "11",
                    "Percentage of patients with treatment-related AE": "26.2%"
                },
                "measures": "[Patients with treatment-related AE]",
                "outcomes": "[11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients with treatment-related AE": "11",
                    "Percentage of patients with treatment-related AE": "26.2%"
                },
                "measures": "[Patients with treatment-related AE]",
                "outcomes": "[11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients with treatment-related AE": "11",
                    "Percentage of patients with treatment-related AE": "26.2%"
                },
                "measures": "[Patients with treatment-related AE]",
                "outcomes": "[11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients with treatment-related AE": "11",
                    "Percentage of patients with treatment-related AE": "26.2%"
                },
                "measures": "[Patients with treatment-related AE]",
                "outcomes": "[11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients with treatment-related AE": "14",
                    "Percentage of patients with treatment-related AE": "6.4%"
                },
                "measures": "[Patients with treatment-related AE]",
                "outcomes": "[14]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients with treatment-related AE": "14",
                    "Percentage of patients with treatment-related AE": "6.4%"
                },
                "measures": "[Patients with treatment-related AE]",
                "outcomes": "[14]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients with treatment-related AE": "14",
                    "Percentage of patients with treatment-related AE": "6.4%"
                },
                "measures": "[Patients with treatment-related AE]",
                "outcomes": "[14]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients with treatment-related AE": "14",
                    "Percentage of patients with treatment-related AE": "6.4%"
                },
                "measures": "[Patients with treatment-related AE]",
                "outcomes": "[14]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients with treatment-related AE": "14",
                    "Percentage of patients with treatment-related AE": "6.4%"
                },
                "measures": "[Patients with treatment-related AE]",
                "outcomes": "[14]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients with treatment-related AE": "14",
                    "Percentage of patients with treatment-related AE": "6.4%"
                },
                "measures": "[Patients with treatment-related AE]",
                "outcomes": "[14]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients with treatment-related AE": "14",
                    "Percentage of patients with treatment-related AE": "6.4%"
                },
                "measures": "[Patients with treatment-related AE]",
                "outcomes": "[14]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients with treatment-related AE": "14",
                    "Percentage of patients with treatment-related AE": "6.4%"
                },
                "measures": "[Patients with treatment-related AE]",
                "outcomes": "[14]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing events": "6",
                    "Percentage of patients experiencing events": "14.3%"
                },
                "measures": "[Patients experiencing events]",
                "outcomes": "[6]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing events": "6",
                    "Percentage of patients experiencing events": "14.3%"
                },
                "measures": "[Patients experiencing events]",
                "outcomes": "[6]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing events": "6",
                    "Percentage of patients experiencing events": "14.3%"
                },
                "measures": "[Patients experiencing events]",
                "outcomes": "[6]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing events": "6",
                    "Percentage of patients experiencing events": "14.3%"
                },
                "measures": "[Patients experiencing events]",
                "outcomes": "[6]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing events": "6",
                    "Percentage of patients experiencing events": "14.3%"
                },
                "measures": "[Patients experiencing events]",
                "outcomes": "[6]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing events": "6",
                    "Percentage of patients experiencing events": "14.3%"
                },
                "measures": "[Patients experiencing events]",
                "outcomes": "[6]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing events": "6",
                    "Percentage of patients experiencing events": "14.3%"
                },
                "measures": "[Patients experiencing events]",
                "outcomes": "[6]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing events": "6",
                    "Percentage of patients experiencing events": "14.3%"
                },
                "measures": "[Patients experiencing events]",
                "outcomes": "[6]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing events": "9",
                    "Percentage of patients experiencing events": "4.1%"
                },
                "measures": "[Patients experiencing events]",
                "outcomes": "[9]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing events": "9",
                    "Percentage of patients experiencing events": "4.1%"
                },
                "measures": "[Patients experiencing events]",
                "outcomes": "[9]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing events": "9",
                    "Percentage of patients experiencing events": "4.1%"
                },
                "measures": "[Patients experiencing events]",
                "outcomes": "[9]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing events": "9",
                    "Percentage of patients experiencing events": "4.1%"
                },
                "measures": "[Patients experiencing events]",
                "outcomes": "[9]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing events": "9",
                    "Percentage of patients experiencing events": "4.1%"
                },
                "measures": "[Patients experiencing events]",
                "outcomes": "[9]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing events": "9",
                    "Percentage of patients experiencing events": "4.1%"
                },
                "measures": "[Patients experiencing events]",
                "outcomes": "[9]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing events": "9",
                    "Percentage of patients experiencing events": "4.1%"
                },
                "measures": "[Patients experiencing events]",
                "outcomes": "[9]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Event severity": "Grade 3 or 4",
                    "Patients experiencing events": "9",
                    "Percentage of patients experiencing events": "4.1%"
                },
                "measures": "[Patients experiencing events]",
                "outcomes": "[9]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        }
    ],
    "total_extracted_claims": 18,
    "total_ground_truth_claims": 10,
    "number_of_matches": 2
}